Crinetics Pharmaceuticals, Inc. (CRNX)
47.86
+0.46
(+0.96%)
USD |
NASDAQ |
Dec 09, 16:00
47.86
0.00 (0.00%)
After-Hours: 16:14
Crinetics Pharmaceuticals Profit Margin (Quarterly): -90.97K% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Eli Lilly & Co. | 31.72% |
| Amgen, Inc. | 33.55% |
| Madrigal Pharmaceuticals, Inc. | -39.75% |
| United Therapeutics Corp. | 42.36% |
| NovaBay Pharmaceuticals, Inc. | -255.9% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -37.41% |
| Return on Assets | -32.49% |
| Return on Invested Capital | -35.80% |
| Gross Profit Margin (Quarterly) | -607.7% |
| Operating Margin (Quarterly) | -99.71K% |
| Return on Net Operating Assets | -698.3% |